Literature DB >> 25466896

Mechanism of choline deficiency and membrane alteration in postural orthostatic tachycardia syndrome primary skin fibroblasts.

Laila C Schenkel1, Ratnesh K Singh1, Vera Michel1, Steven H Zeisel1, Kerry-Ann da Costa1, Amy R Johnson1, Harvey S Mudd1, Marica Bakovic2.   

Abstract

Fibroblasts from a patient with postural orthostatic tachycardia syndrome (POTS), who presented with low plasma choline and betaine, were studied to determine the metabolic characteristics of the choline deficiency. Choline is required for the synthesis of the phospholipid phosphatidylcholine (PC) and for betaine, an important osmoregulator. Here, choline transport, lipid homeostasis, and mitochondria function were analyzed in skin fibroblasts from POTS and compared with control cells. The choline transporter-like protein 1/solute carrier 44A1 (CTL1/SLC44A1) and mRNA expression were 2-3 times lower in POTS fibroblasts, and choline uptake was reduced 60% (P < 0.05). Disturbances of membrane homeostasis were observed by reduced ratios between PC:phosphatidylethanolamine and sphingomyelin:cholesterol, as well as by modified phospholipid fatty acid composition. Choline deficiency also impaired mitochondria function, which was observed by a reduction in oxygen consumption, mitochondrial potential, and glycolytic activity. When POTS cells were treated with choline, transporter was up-regulated, and uptake of choline increased, offering an option for patient treatment. The characteristics of the POTS fibroblasts described here represent a first model of choline and CTL1/SLC44A1 deficiency, in which choline transport, membrane homeostasis, and mitochondrial function are impaired. © FASEB.

Entities:  

Keywords:  CTL1/SLC44A1; choline transport; mitochondria; phospholipids

Mesh:

Substances:

Year:  2014        PMID: 25466896      PMCID: PMC4415014          DOI: 10.1096/fj.14-258566

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  41 in total

Review 1.  The methylation of phosphatidylethanolamine.

Authors:  D E Vance; N D Ridgway
Journal:  Prog Lipid Res       Date:  1988       Impact factor: 16.195

2.  Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver.

Authors:  S H Zeisel; T Zola; K A daCosta; E A Pomfret
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

3.  The concentration of phosphatidylethanolamine in mitochondria can modulate ATP production and glucose metabolism in mice.

Authors:  Jelske N van der Veen; Susanne Lingrell; Robin P da Silva; René L Jacobs; Dennis E Vance
Journal:  Diabetes       Date:  2014-03-27       Impact factor: 9.461

4.  Choline, an essential nutrient for humans.

Authors:  S H Zeisel; K A Da Costa; P D Franklin; E A Alexander; J T Lamont; N F Sheard; A Beiser
Journal:  FASEB J       Date:  1991-04       Impact factor: 5.191

5.  Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1.

Authors:  Zongfei Yuan; Angela Tie; Mark Tarnopolsky; Marica Bakovic
Journal:  Physiol Genomics       Date:  2006-04-11       Impact factor: 3.107

6.  Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets.

Authors:  Lucy Bakewell; Graham C Burdge; Philip C Calder
Journal:  Br J Nutr       Date:  2006-07       Impact factor: 3.718

7.  The effect of choline deficiency on the outer membranes of rat liver mitochondria.

Authors:  C M Filipowicz; R B McCauley
Journal:  Biochim Biophys Acta       Date:  1983-10-12

8.  Sex and menopausal status influence human dietary requirements for the nutrient choline.

Authors:  Leslie M Fischer; Kerry Ann daCosta; Lester Kwock; Paul W Stewart; Tsui-Shan Lu; Sally P Stabler; Robert H Allen; Steven H Zeisel
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

9.  The choline transporter is the major site of control of choline oxidation in isolated rat liver mitochondria.

Authors:  C P Kaplan; R K Porter; M D Brand
Journal:  FEBS Lett       Date:  1993-04-19       Impact factor: 4.124

Review 10.  Choline: an important nutrient in brain development, liver function and carcinogenesis.

Authors:  S H Zeisel
Journal:  J Am Coll Nutr       Date:  1992-10       Impact factor: 3.169

View more
  6 in total

Review 1.  Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.

Authors:  Vera Hedtke; Marica Bakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-18

2.  Male-Specific Cardiac Dysfunction in CTP:Phosphoethanolamine Cytidylyltransferase (Pcyt2)-Deficient Mice.

Authors:  Poulami Basu; Faisal J Alibhai; Elena V Tsimakouridze; Ratnesh K Singh; Sabina Paglialunga; Graham P Holloway; Tami A Martino; Marica Bakovic
Journal:  Mol Cell Biol       Date:  2015-05-18       Impact factor: 4.272

Review 3.  Choline metabolites: gene by diet interactions.

Authors:  Tangi Smallwood; Hooman Allayee; Brian J Bennett
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

4.  Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation.

Authors:  Amy R Johnson; Yuanyuan Qin; Alyssa J Cozzo; Alex J Freemerman; Megan J Huang; Liyang Zhao; Brante P Sampey; J Justin Milner; Melinda A Beck; Blossom Damania; Naim Rashid; Joseph A Galanko; Douglas P Lee; Matthew L Edin; Darryl C Zeldin; Patrick T Fueger; Brittney Dietz; Andreas Stahl; Ying Wu; Karen L Mohlke; Liza Makowski
Journal:  Mol Metab       Date:  2016-04-23       Impact factor: 7.422

Review 5.  Membrane lipid raft homeostasis is directly linked to neurodegeneration.

Authors:  Tobias Moll; Jack N G Marshall; Nikita Soni; Sai Zhang; Johnathan Cooper-Knock; Pamela J Shaw
Journal:  Essays Biochem       Date:  2021-12-22       Impact factor: 8.000

6.  Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.

Authors:  Hirotaka Iwaki; Cornelis Blauwendraat; Hampton L Leonard; Jonggeol J Kim; Ganqiang Liu; Jodi Maple-Grødem; Jean-Christophe Corvol; Lasse Pihlstrøm; Marlies van Nimwegen; Samantha J Hutten; Khanh-Dung H Nguyen; Jacqueline Rick; Shirley Eberly; Faraz Faghri; Peggy Auinger; Kirsten M Scott; Ruwani Wijeyekoon; Vivianna M Van Deerlin; Dena G Hernandez; J Raphael Gibbs; Kumaraswamy Naidu Chitrala; Aaron G Day-Williams; Alexis Brice; Guido Alves; Alastair J Noyce; Ole-Bjørn Tysnes; Jonathan R Evans; David P Breen; Karol Estrada; Claire E Wegel; Fabrice Danjou; David K Simon; Ole Andreassen; Bernard Ravina; Mathias Toft; Peter Heutink; Bastiaan R Bloem; Daniel Weintraub; Roger A Barker; Caroline H Williams-Gray; Bart P van de Warrenburg; Jacobus J Van Hilten; Clemens R Scherzer; Andrew B Singleton; Mike A Nalls
Journal:  Mov Disord       Date:  2019-09-10       Impact factor: 9.698

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.